|
Memórias do Instituto Oswaldo Cruz
Fundação Oswaldo Cruz, Fiocruz
ISSN: 1678-8060 EISSN: 1678-8060
Vol. 90, Num. 4, 1995, pp. 503-506
|
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol.
90(4): 503-506 Jul/Aug. 1995
Characterization of T Cell Clones from Chagasic Patients:
Predominance of CD8 Surface Phenotype in Clones from Patients
with Pathology
Washington R Cuna, Celeste Rodriguez Cuna
Departamento de Parasitologia, Instituto Boliviano de Biologia
de Altura, Facultad de Medicina,
Casilla 641, La Paz, Bolivia
Code Number: OC95098
Size of Files:
Text: 15K
No associated graphics
Human Chagas' disease, caused by the protozoan
Trypanosoma cruzi, is associated with pathological
processes whose mechanisms are not known. To address this
question, T cell lines were developed from chronic chagasic
patients peripheral blood mononuclear cells (PBMC) and cloned.
These T cell clones (TCC) were analyzed phenotypically with
monoclonal antibodies by the use of a fluorescence microscope.
The surface phenotype of the TCC from the asymptomatic patient
were predominantly CD4 positive (86%). On the contrary, the
surface phenotype CD8 was predominant in the TCC from the
patients suffering from cardiomegaly with right bundle branch
block (83%), bradycardia with megacolon (75%) and bradycardia
(75%). Future studies will be developed in order to identify
the antigens eliciting these T cell subpopulations.
Key words: Trypanosoma cruzi - T cell clones -
asymptomatic - pathology
Chagas' disease, whose causative agent is the protozoan
Trypanosoma cruzi, is characterized by an acute often
asymptomatic phase which proceeds through a latent period of
variable length. A percentage of those infected pass into the
more pathological, chronic stage of the disease characterized
by damage to the cardiovascular or the digestive system as
well as nervous tissue (Amorim et al. 1979, De Rezende
1979, Teixeira 1987, Tanowitz et al. 1992). Cell
mediated immune mechanisms have been implicated in the
immunopathology of experimental Chagas' disease (Said et
al. 1985, Mortatti et al. 1990, Spinella et
al. 1990, Ribeiro dos Santos et al. 1992). In
contrast, the event mechanisms leading to immunopathology in
human T. cruzi infections are not fully understood. The
approach made in the present work was the development and
characterization of TCC derived from T cell lines of four
chronic chagasic patients; one asymptomatic and three with
pathology. Only one previous study (Britten & Hudson 1985)
described the isolation of a T. cruzi specific T cell
line with the T4 surface phenotype from a chagasic patient. In
this work we set out to analyze if the pattern of reactivity
described above is characteristic of human T. cruzi
infections or if there is an association between the clinical
manifestations of Chagas' disease and a particular T cell
subset. The results of this study show that different patterns
of TCC were obtained from these patients in terms of the
symptomatology of Chagas' disease.
MATERIALS AND METHODS
Parasites - The Tulahuen strain of T. cruzi was used in
this work. Tissue culture trypomastigotes were obtained from
the supernatants of Vero cells cultured in RPMI 1640 (GIBCO,
Grand Island, NY, USA) containing 2% heat-inactivated (56 C,
30 min) FCS initially infected with trypomastigotes and
maintained at 37 C, CO2 for five days.
Antigen - Culture supernatants were centrifuged at 1800 x g
for 10 min and incubated at 37 C for 2 hr to yield a
supernatant containing highly motile trypomastigotes without
debris. Parasites were resuspended at 1 to 2x10^7
trypomastigotes per ml in RPMI medium containing 10% FCS, 100
IU of penicillin and 100 ug of streptomycin per ml referred to
in the text as complete medium. Soluble antigens were prepared
through four cycles of freezing (-20 C) and thawing the latter
suspension. This material was assayed for protein content,
aliquoted and stored at -20 C until used.
Cells - Blood was drawn from four chronic chagasic patients
with positive serology for T. cruzi (indirect
immunofluorescence and ELISA tests) and one patient with
positive xenodiagnos. The asymptomatic patient, had normal ECG
and chest X-ray and followed a clinical examination. Three
patients presented clinical symptoms associated with cardiac
disease and gastrointestinal lesions. PBMC were purified by
centrifugation (400 x g, 20 C, 45 min) over a mixture of
Ficoll Hypaque of density 1.077. After two washings with
serum free medium, the cells were resuspended at the desired
concentration in complete medium. The cell viability of PBMC
suspensions was consistently >99% as determined by trypan
blue exclusion.
Culture and cloning procedure - Fresh PBMC from the chagasic
patients were cultured at 2 x 10^6 cells per ml in complete
medium (5% CO2 , 24 well plate) at 37 C in the presence of
antigen. Throughout the study the antigen was used at a
protein content of 20 ug/ml final concentration. After eight
days of culture, viable cells were separated on Ficoll Hypaque
gradient and cultured with antigen in the presence of
mitomycin C treated (50 ug/ml) autologous PBMC (maPBMC) at a
ratio of 4 x 10^5 viable cells to 1.6 x 10^6 maPBMC. Three
cycles of restimulation with antigen were repeated before
cloning. Cells were cloned by limiting dilution in 96 well
microculture trays by plating 1, 2 or 3 cells/well onto 5 x
10^4 maPBMC in 200 ul of complete medium and antigen. Positive
wells were scored by viewing in an inverted microscope after
12-14 days in culture. The T cell clones were subcloned once
and then received alternative restimulations in the presence
of maPBMC/antigen, in medium supplemented with 10 IU of
purified recombinant human interleukin-2 (Genzyme, Cambridge,
MA, USA) or 5 x 10^4 fresh allogeneic PBMC treated with
mytomicin C as feeder cells and 1 ug/ml
phytohaemagglutinin.
Surface phenotyping - Lymphocytes (1.5 x 106 per 5 ml tube)
were washed twice in phosphate buffered saline (PBS)
containing 1% bovine serum albumin (BSA) and incubated in
different eppendorf tubes during 30 min at 4 C with monoclonal
antibodies defining human T cell (OKT11), human CD4 T cell
(OKT4) or human CD8 T cell (OKT8) epitopes (Ortho Diagnostics
System, Raritan, NJ, USA). After washing two times with
PBS/BSA the cells were incubated (30 min, 4 C) with 100 ul of
Ortho fluorescein-isothiocyanate-conjugated goat anti-mouse
IgG antibody, diluted 1:20 in cold PBS. After two washings
with PBS/BSA the cells were recovered in 100 ul of 90%
glycerol in PBS containing 0.1% sodium azide and examined on a
fluorescence microscope. Nonspecific mouse immunoglobulin was
used as control for nonspecific staining.
RESULTS
The TCC were obtained from three chagasic patients with
clinical symptoms and one asymptomatic patient (Table) by
stimulation with a soluble extract of trypomastigotes of the
Tulahuen strain of T. cruzi.
As reported in a previous study (Britten & Hudson 1985) the
best cloning efficiencies of the TCC by limiting dilution were
obtained from wells plated at 3 cells/culture and were as
follows: 28%, 30%, 20% and 18% for patients C, A, F and G
respectively. These percentages of efficiency are reflected in
the total number of clones obtained from each patient
(Table).
The phenotype of the TCC which were maintained in continuous
culture for seven months were characterized using a panel of
anti-T cell antibodies (Table). Given the limited supply of
APC, clones were chosen at random from the original total
number which were maintained in culture and further analyzed
for its surface phenotype. The results of this
characterization are shown in the Table. The TCC derived from
the asymptomatic patient C were predominantly CD4 positive
(86%). On the contrary TCC obtained from the symptomatic
patients were in its majority CD8 positive.
TABLE
Cell surface phenotype of T-cell clones grown from chagastic
patients
------------------------------------------------------------
% Positive T cell clones
Patient Clinical form No. of TCC --------------------------
OKT4 OKT8 OKT11
------------------------------------------------------------
C Asymptomatic 89(37) 86 14 100
A Cardiac 72(30) 17 83 100
F Cardiac-digestive 19(140 25 75 100
G Cardiac 26(18) 25 75 100
------------------------------------------------------------
Number of analysed TCC shown in parenthesis
A: cardiomegaly with right bundle branch block
F: bradycardia with megacolon
G: bradycardia
DISCUSSION
The immediate aim of the present investigation was to produce
TCC from chronic chagasic patients with different symptoms and
characterize their surface phenotype. Accordingly, PBMC
obtained from these patients followed four cycles of T.
cruzi trypomastigotes stimulation so that the resulting T
cell blasts would be comprised exclusively of antigen-specific
cells and hence the TCC resulting from these blasts would be
of predefined specificity. The in vitro model system we used
in this work to generate TCC from chagasic patients has
allowed us to observe a correlation between the clinical
status of the T. cruzi infection and the CD4 or CD8
surface phenotype.
The strain and the stage of T. cruzi used in this study
were chosen because this strain is highly virulent in the
mouse model and the trypomastigote is the extracellular
infective stage and hence the most likely to be exposed to the
immune response of the host. Furthermore, the trypomastigote
stage has been shown to be highly potent in terms of
stimulating T cells (Nickell et al. 1987).
This work supports previous reports where the inflammatory
heart lesions of six chagasic patients were dominated by CD8
positive lymphocytes (D'Avila Reis et al. 1993) and a
more recent study by Tostes et al. (1994) in which CD8+
cells were more numerous than CD4+ lymphocytes in myocardial
exsudate of necropsied chagasic patients. Equally, this study
becomes more relevant in view of the role of CD4 positive T
cells in the pathogenesis of experimental Chagas' disease (Ben
Younes-Chennoufi et al. 1988, Russo et al. 1988,
Ribeiro dos Santos et al. 1990) and mainly the
importance of CD8+ T cells in control and immune protection in
T. cruzi infection in mice (Tarleton et al.
1992, Nickell et al. 1993, Sun & Tarleton 1993).
These results open the possibility of investigating the
mechanisms of the pathology of Chagas' disease by defining a
model of study which should help to identify the antigens
inducing T-lymphocyte immune responses. Future efforts will be
directed towards the identification of the relevant parasite
molecules.
REFERENCES
Amorim DS, Manco JC, Gallo Jr L, Neto JAM 1979. Clinica: Forma
Cardiaca, p. 265-311. In Z Brener, Z Andrade (eds).
Trypanosoma cruzi e Doenca de Chagas. Guanabara Koogan,
Rio de Janeiro.
Ben Younes-Chennoufi A, Said G, Eisen H, Durand A,
Hontebeyrie-Joskowicz M 1988. Cellular immunity to
Trypanosoma cruzi is mediated by helper T cells (CD4+).
Trans R Soc Trop Med Hyg 82: 84-89.
Britten V, Hudson L 1985. Isolation and characterization of
human T-cell lines from a patient with Chagas' disease. Lancet
2: 637-639.
D'Avila Reis D, Jones EM, Tostes Jr S, Reis Lopes E,
Gazzinelli G, Colley DG, McCurley TL 1993. Characterization of
inflammatory infiltrates in chronic chagasic myocardial
lesions: presence of tumor necrosis factor-a+ cells and
dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg
48: 637-644.
De Rezende JM 1979. Clinica: Manifestacoes Digestivas, p.
312-361. In Z Brener, Z Andrade (eds). Trypanosoma
cruzi e Doenca de Chagas. Guanabara Koogan, Rio de
Janeiro.
Mortatti RC, Maia LC, De Oliveira AV, Munk M 1990.
Immunopathology of experimental Chagas' disease: binding of T
cells to Trypanosoma cruzi-infected heart tissue.
Infect Immun 58: 3588-3593.
Nickell SP, Gebremichael A, Hoff R, Boyer MH 1987. Isolation
and functional characterization of murine T cell lines and
clones specific for the protozoan parasite Trypanosoma
cruzi. J Immunol 138: 914-921.
Nickell SP, Stryker GA, Arevalo C 1993. Isolation from
Trypanosoma cruzi-infected mice of CD8+, MHC-restricted
cytotoxic T cells that lyse parasite-infected target cells. J
Immunol 150: 1446-1457.
Ribeiro dos Santos R, Laus JL, Mengel JO, Savino W 1990.
Chronic chagasic cardiopathy: role of CD4 T cells in the
anti-heart autoreactivity. Mem Inst Oswaldo Cruz 85:
367-369.
Ribeiro dos Santos R, Rossi MA, Kaus JL, Silva JS, Savino W,
Mengel J 1992. Anti-CD4 abrogates rejection and reestablishes
long-term tolerance to syngeneic newborn hearts grafted in
mice chronically infected with Trypanosoma cruzi. J Exp
Med 175: 29-39.
Russo M, Starobinas N, Minoprio P, Coutinho A,
Hontebeyrie-Joskowicz M 1988. Parasite load increases and
myocardial inflammation decreases in Trypanosoma
cruzi-infected mice after inactivation of helper T cells.
Ann Immunol (Inst Pasteur) 139: 225-236.
Said G, Joskowicz M, Barreira AA, Eisen H 1985. Neuropathy
associated with experimental Chagas' disease. Ann Neurol 18:
676-783.
Spinella S, Milon G, Hontebeyrie-Joskowicz M 1990. A CD4 Th2
cell line from mice chronically infected with Trypanosoma
cruzi induces IgG2 polyclonal response in vivo. Europ J
Immunol 20: 1045-1051.
Sun J, Tarleton RL 1993. Predominance of CD8+ T lymphocytes in
the inflammatory lesions of mice with acute Trypanosoma
cruzi infection. Am J Trop Med Hyg 48: 161-169.
Tanowitz HB, Kirchhoff LV, Simon D, Morris SA, Weiss LM,
Wittner M 1992. Chagas' Disease. Clin Microbiol Rev 5:
400-419.
Tarleton RL, Koller BH, Latour A, Postan M 1992.
Susceptibility of b2-microglobulin-deficient mice to
Trypanosoma cruzi infection. Nature 356: 338-340.
Teixeira ARL 1987. The stercorarian trypanosomes, p. 25-117.
In EJL Soulsby, Immune responses in parasitic infections:
Immunology, immunopathology and immunoprophylaxis. CRC Press,
Boca Raton, FL.
Tostes Jr S, Lopes ER, Lima Pereira FE, Chapadeiro E 1994.
Miocardite chagasica cronica humana: Estudo quantitativo dos
linfocitos CD4+ e dos CD8+ no exsudato inflamatorio. Rev Soc
Bras Med Trop 27: 127-134.
Copyright 1995 Fundacao Oswaldo Cruz
|